BridgeBio Inc. is seeking a Skeletal Dysplasia Account Manager to drive the launch of Infigratinib for achondroplasia and to work with providers and families across a Southwest Region territory. This role emphasizes deep clinical acumen, urgency, and a strong partnering approach with healthcare professionals and patients.
The candidate will lead a cross-functional launch, engage KOLs, and build territory plans with a focus on compliant scientific discussions and patient-centered outcomes.
#J-18808-LjbffrRemote Skeletal Dysplasia Account Executive in nashville at Unknown Company
This position is listed as full time and onsite.